Last $66.53 USD
Change Today -0.06 / -0.09%
Volume 6.5M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregory D. Plowman M.D., Ph.D.

Vice President of Oncology Research and Senior Vice President of ImClone Systems Research, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 96 board members in 1 different organizations across 3 different industries.

See Board Relationships
57--

Background*

Dr. Gregory D. Plowman, also known as Greg, M.D., Ph.D. has been Vice President of Oncology Research and Senior Vice President of ImClone Systems Research at Eli Lilly and Company since March 28, 2011. Dr. Plowman oversees the oncology research efforts of Lilly and ImClone. Dr. Plowman has over 25 years of experience in cancer research including leadership roles at four biotechs (Oncogen, Sugen, Exelixis Inc., and Genentech). Dr. Plowman served as Senior Vice President ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Washington
MD
University of Washington
BA
Whitman College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $66.53 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.